Consolidated Statement of Comprehensive Income For the Year Ended 30 June 2026 Consolidated Entity 2026 2025 Notes US$m US$m Sales and service revenue 15,212 15,035 Influenza pandemic facility reservation fees 183 179 Royalties and license revenue 303 216 Other income 99 128 Total operating revenue 2 15,797 15,558 Cost of sales (7,722) (7,479) Gross profit 8,075 8,079 Research and development expenses 7 (1,223) (1,359) Selling and marketing expenses (1,691) (1,616) General and administration expenses (920) (1,000) Restructuring and impairment expenses 3 (7,923) — Total expenses (11,757) (3,975) Net gain on business disposals — 30 Operating (loss)/profit (EBIT) (3,682) 4,134 Finance costs 2 (435) (448) Finance income 30 38 (Loss)/profit before tax (4,087) 3,724 Income tax benefit/(expense) 4 1,101 (588) Net (loss)/profit for the year (2,986) 3,136 Other comprehensive income (OCI) Items that may be reclassified subsequently to profit or loss Hedging transactions realised in profit or loss 12 (12) (12) Exchange differences on translation of foreign operations, net of gain reclassified to profit or loss upon the disposal of foreign operations in the prior year 12 63 68 Items that will not be reclassified subsequently to profit or loss Changes in fair value on equity securities measured through OCI, net of tax 12 (21) 19 Actuarial (losses)/gains on defined benefit plans, net of tax 12 (55) 64 Total other comprehensive (losses)/income (25) 139 Total comprehensive (losses)/income for the year (3,011) 3,275 Net (loss)/profit for the year attributable to: (2,986) 3,136 - Shareholders of CSL Limited (2,579) 3,002 - Non-controlling interests (407) 134 Total comprehensive (loss)/income for the year attributable to: (3,011) 3,275 - Shareholders of CSL Limited (2,604) 3,141 - Non-controlling interests (407) 134 (Loss)/earnings per share (based on net (loss)/profit attributable to CSL Limited shareholders for the year) US$ US$ Basic (loss)/earnings per share 10 (5.35) 6.20 Diluted (loss)/earnings per share 10 (5.35) 6.17 The consolidated statement of comprehensive income should be read in conjunction with the accompanying notes. 88 For the Year Ended 30 June 2026 88 Financial Report
RkJQdWJsaXNoZXIy MjE2NDg3